Vetmedin 10 mg Flavoured Chewable Tablets for Dogs

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

PIMOBENDAN

제공처:

Boehringer Ingelheim Animal Health Australia Pty. Ltd.

약제 형태:

ORAL BOLUS, CHEWABLE

구성:

PIMOBENDAN PYRIDAZINONE Active 10.0 mg/Tb

패키지 단위:

100 tablets; 50 tablets

수업:

VM - Veterinary Medicine

치료 영역:

CARDIOVASCULAR SYSTEM

제품 요약:

Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [CONGESTIVE HEART FAILURE, PRECLINICAL MYXOMATOUS MITRAL VALVE DISEASE]; DOG - LARGE: [PRECLINICAL DCM, PRECLINICAL MYXOMATOUS MITRAL VALVE DISEASE]

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

Vetmedin 10 mg Flavoured Chewable Tablets for Dogs
84154/109799
Product Name:
APVMA Approval No:
Label Name:
Vetmedin 10 mg Flavoured Chewable Tablets for Dogs
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Each tablet contains 10 mg pimobendan
Claims:
Vetmedin Flavoured Chewable Tablets are indicated for:
The treatment of canine congestive heart failure (CHF) originating
from dilated
cardiomyopathy (DCM) or valvular insufficiency (mitral and/ or
tricuspid regurgitation).
The treatment of pre-clinical DCM in large breed dogs. When used in
cases of preclinical
DCM in large breed dogs, pimobendan significantly prolonged the time
to the onset of CHF
or sudden death, and also resulted in prolongation of the time to
death due to all causes.
Doberman Pinscher dogs with preclinical DCM treated with pimobendan
also demonstrated
a significant reduction in Left Ventricular Internal Diameter in both
systole and diastole
( LVIDs/d) in response to therapy.
For the treatment of dogs with evidence of increased heart size
secondary to asymptomatic
(preclinical) myxomatous mitral valve disease to delay the onset of
clinical symptoms of
heart failure, to reduce heart size and to increase survival time.
Net Contents:
50 tablets
100 tablets
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated for use in cases of hypertrophic
cardiomyopathies or clinical
conditions where an augmentation of cardiac output is not recommended
for functional or
anatomical reasons (e.g. aortic stenosis). RLP APPROVED
Precautions:
Vetmedin Flavoured Chewable Tablets should only be administered to
pregnant and
lactating bitches if the expected therapeutic benefits overweigh the
potential risk.
Studies into the effect of pimobendan on the reproductive function of
male dogs have not
been conducted.
In pharmacological studies no interaction between the cardiac
glycoside ouabain and
pimobendan was detected. The pimobendan induced increase in
contractility